Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin

This publication has 71 references indexed in Scilit:

• Unraveling the role of proteases in cancer
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 2000
• The plasminogen activation system in tumor growth, invasion, and metastasis
  Cellular and Molecular Life Sciences, 2000
• Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types
  APMIS, 1999
• Photoaffinity Labeling of the Human Receptor for Urokinase-Type Plasminogen Activator Using a Decapeptide Antagonist. Evidence for a Composite Ligand-Binding Site and a Short Interdomain Separation
  Biochemistry, 1998
• Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
  Proceedings of the National Academy of Sciences, 1996
• Ligand Interaction between Urokinase-Type Plasminogen Activator and Its Receptor Probed with 8-Anilino-1-naphthalenesulfonate. Evidence for a Hydrophobic Binding Site Exposed Only on the Intact Receptor
  Biochemistry, 1994
• Cell‐induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH₂‐terminal domain of the urokinase receptor
  FEBS Letters, 1991
• Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
  The Journal of cell biology, 1989
• Plasminogen Activation Initiated by Single-chain Urokinase-type Plasminogen Activator
  Journal of Biological Chemistry, 1989
• Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody
  Biochemistry, 1982